Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

6 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT04425421Recruiting

Recommendations for the Treatment of Children With Burkitt's Lymphoma

Role: lead

NCT04423484Recruiting

Therapeutic Recommendations for Nephroblastoma

Role: lead

NCT04794296Recruiting

Recommendations for the Treatment of Children With Acute Lymphoblastic Leukemia in the GFAOP

Role: lead

NCT04425434Recruiting

Therapeutic Recommendations For The Treatment Of Children With A Retinoblastoma

Role: lead

NCT05407480Recruiting

Thereapeutic Recommendantion for Children With a Hodgkin Lymphoma

Role: lead

NCT03803735Recruiting

Hospital Based Registry of Childhood Cancer in Pediatric Oncology Units in French Speaking Africa

Role: lead

All 6 trials loaded